Literature DB >> 17761683

Early developmental pathology due to cytochrome c oxidase deficiency is revealed by a new zebrafish model.

Katrina N Baden1, James Murray, Roderick A Capaldi, Karen Guillemin.   

Abstract

Deficiency of cytochrome c oxidase (COX) is associated with significant pathology in humans. However, the consequences for organogenesis and early development are not well understood. We have investigated these issues using a zebrafish model. COX deficiency was induced using morpholinos to reduce expression of CoxVa, a structural subunit, and Surf1, an assembly factor, both of which impaired COX assembly. Reduction of COX activity to 50% resulted in developmental defects in endodermal tissue, cardiac function, and swimming behavior. Cellular investigations revealed different underlying mechanisms. Apoptosis was dramatically increased in the hindbrain and neural tube, and secondary motor neurons were absent or abnormal, explaining the motility defect. In contrast, the heart lacked apoptotic cells but showed increasingly poor performance over time, consistent with energy deficiency. The zebrafish model has revealed tissue-specific responses to COX deficiency and holds promise for discovery of new therapies to treat mitochondrial diseases in humans.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17761683     DOI: 10.1074/jbc.M703528200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  22 in total

Review 1.  Trolling for the ideal model host: zebrafish take the bait.

Authors:  Jonathan P Allen; Melody N Neely
Journal:  Future Microbiol       Date:  2010-04       Impact factor: 3.165

2.  Mitochondrial Factors and VACTERL Association-Related Congenital Malformations.

Authors:  S Siebel; B D Solomon
Journal:  Mol Syndromol       Date:  2013-02

3.  Pharmacologic modeling of primary mitochondrial respiratory chain dysfunction in zebrafish.

Authors:  James Byrnes; Rebecca Ganetzky; Richard Lightfoot; Michael Tzeng; Eiko Nakamaru-Ogiso; Christoph Seiler; Marni J Falk
Journal:  Neurochem Int       Date:  2017-07-18       Impact factor: 3.921

Review 4.  MicroRNAs in pancreatic cancer metabolism.

Authors:  Pankaj K Singh; Randall E Brand; Kamiya Mehla
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-04-17       Impact factor: 46.802

5.  Imbalanced mitochondrial function provokes heterotaxy via aberrant ciliogenesis.

Authors:  Martin D Burkhalter; Arthi Sridhar; Pedro Sampaio; Raquel Jacinto; Martina S Burczyk; Cornelia Donow; Max Angenendt; Maja Hempel; Paul Walther; Petra Pennekamp; Heymut Omran; Susana S Lopes; Stephanie M Ware; Melanie Philipp
Journal:  J Clin Invest       Date:  2019-05-16       Impact factor: 14.808

6.  VACTERL association and mitochondrial dysfunction.

Authors:  Benjamin D Solomon; Ankita Patel; Sau Wai Cheung; Daniel E Pineda-Alvarez
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2011-02-09

7.  The zebrafish embryo as a dynamic model of anoxia tolerance.

Authors:  Bryce A Mendelsohn; Bethany L Kassebaum; Jonathan D Gitlin
Journal:  Dev Dyn       Date:  2008-07       Impact factor: 3.780

8.  Severe infantile encephalomyopathy caused by a mutation in COX6B1, a nucleus-encoded subunit of cytochrome c oxidase.

Authors:  Valeria Massa; Erika Fernandez-Vizarra; Saad Alshahwan; Eman Bakhsh; Paola Goffrini; Ileana Ferrero; Paolo Mereghetti; Pio D'Adamo; Paolo Gasparini; Massimo Zeviani
Journal:  Am J Hum Genet       Date:  2008-05-22       Impact factor: 11.025

9.  How mitochondrial dysfunction affects zebrafish development and cardiovascular function: an in vivo model for testing mitochondria-targeted drugs.

Authors:  Brígida R Pinho; Miguel M Santos; Anabela Fonseca-Silva; Patrícia Valentão; Paula B Andrade; Jorge M A Oliveira
Journal:  Br J Pharmacol       Date:  2013-07       Impact factor: 8.739

Review 10.  Mitochondrial cytochrome c oxidase deficiency.

Authors:  Malgorzata Rak; Paule Bénit; Dominique Chrétien; Juliette Bouchereau; Manuel Schiff; Riyad El-Khoury; Alexander Tzagoloff; Pierre Rustin
Journal:  Clin Sci (Lond)       Date:  2016-03       Impact factor: 6.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.